title: Upfront combination therapy: does the AMBITION study herald a new era in the treatment of pulmonary arterial hypertension?
authors.affiliation: Advanced Lung Disease and Transplant Program, Department of Medicine, Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
authors.forename: Steven D
authors.initials: SD
authors.lastname: Nathan
authors.affiliation: Institute of Cellular Medicine, Newcastle University and The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
authors.forename: Paul A
authors.initials: PA
authors.lastname: Corris
mesh_terms: D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000379:methods; D004359:Drug Therapy, Combination; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents
keywords: Primary Pulmonary Hypertension